期刊文献+

应用流式细胞术检测原发免疫性血小板减少症患者血小板膜糖蛋白Ⅱb/Ⅲa的表达及其临床意义 被引量:4

原文传递
导出
摘要 免疫性血小板减少症(Primary immune thrombocytopenia,ITP)是一类由体液和细胞免疫异常导致血小板破坏增多的疾病。发病机制与免疫功能异常引起的自身抗血小板抗体产生关系密切。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2011年第9期630-631,共2页 Chinese Journal of Hematology
  • 相关文献

参考文献7

二级参考文献13

  • 1肖太武,侯明,李光耀,葛芙蓉,杨锡明,王景霞,栾静,赵歧刚.改良间接MAIPA法对免疫性与非免疫性血小板减少的鉴别诊断价值[J].临床血液学杂志,2006,19(2):101-102. 被引量:7
  • 2张之南.血液病诊断及疗效标准.3版.北京:科学出版社,2008.106-113.
  • 3Cines DB, Blanchette VS. Immune Thrombocytopenic Purpura. N Engl J Med,2002,28(13):995-1008.
  • 4Brighton TA,Evans S,Castaldi PA,et al. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood, 1996,88 ( 1 ):194-201.
  • 5Stockelberg D,Hou M,Jacobsson S,et al. Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura(ITP). a comparative study using flow cytometry,a whole platelet ELISA,and an antigencapture ELISA. Eur J Haematol, 1996,56 ( 1-2):72-75.
  • 6Chong BH, Keng TB. Advances in the diagnosis of idiopathic thrombocytopenic purpura.Semin Hematol, 2000,37 (3):249-260.
  • 7Aledort LM, Hayward CP,Chen MG, et al. Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies. Am J Hematol,2004,76 (3):205-213.
  • 8Hernandez F, Blanquer A, Linares M, et al. Autoimmune thrombocytopenia associated with hepatitis C virus infection. Acta Haematol,1998;99:217-220
  • 9Pereira J, Accatino L, Alfaro J, et al. Platelet autoantibodies in patients with chronic liver disease. Am J Hematol,1995;50:173-178
  • 10曹晓军.小儿特发性血小板减少性紫癜血小板相关抗体、抗血小板抗体、血小板膜糖蛋白检测[J].镇江医学院学报,1999,9(4):536-538. 被引量:2

共引文献25

同被引文献32

  • 1Provan D, Stasi R, Newland AC, et al. International consensus re- port on.the investigation and management of primary immune throm- bocytopenia [ J ]. Blood, 2010,115 (2) : 168-186.
  • 2Cines DB, Blanehette VS. Immune thrombocytopanic purpura[ J]. N Engl J Med, 2002,346 ( 13 ) :995-1008.
  • 3McEver RP. Seleetins [ J]. Curr Opin Immunol, 1994,6 ( 1 ) : 75-84.
  • 4Hayashi S, Oshida M, Kiyokawa T, et al. Determination of activa- ted platelets : evaluation of methodology and application for patients with idiopathic thrombocytopenie pnrpura [ J ]. Rinsho Byori, 2001,49(12) :1287-1292.
  • 5Terrell DR, Beebe LA, Vesely SK, et al. The incidence of im- mune thrombocytopenic purpura in children and adults: a critical review of published reports [ J ]. Am J Hematol, 2010,85 ( 3 ) : 174-180.
  • 6Johnsen J. Pathogenesis in immune thrombocytopenia: new insights [J]. Hematology Am Soc Hematol Educ Program, 2012 (2012) : 306-312.
  • 7Sherernata WA, Jy W, Horstman LL, et al. Evidence of platelet activation in multiple sclerosis [ J ~. J Neuroinflammation, 2008 (5) :27.
  • 8Shattil S J, Cunningham M, Hoxic JA. Detection of activated plate- lets in whole blood using activation-dependent monoelonal antibod-ies and flow cytometry[ J]. Blood, 1987,70(1 ) :307-315.
  • 9Zhou B, Zhao H, Yang RC, et al. Multi-dysfunctional pathophysi- ology in ITP[J]. Crit Rev Oncol Hematol, 2005, 54 (2): 107-116.
  • 10Hezard N, Simon G, Mace C, et al. Is flow cylometry aecurate e-nough to screen platelet autoantibodies [J]. Transfusion, 2008, 48(2):513-518.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部